Term ends Mar 25, 2028 · High confidence
20-year base term ends Jun 14, 2027
Held by Zeon Corporation
Filed Apr 27, 2015 as application 14/697,372 · Granted Dec 18, 2018
Base term plus 332 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2007
2028
Clock starts
Jun 14, 2007
Jun 14, 2007
Term ends
Mar 25, 2028
Mar 25, 2028
Granted
Dec 18, 2018
Dec 18, 2018
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
332
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,273,355.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 332 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 14, 2007, when application 11/763,421, the earliest non-provisional in its chain, was filed (this one was filed Apr 27, 2015) | Jun 14, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +332 days, USPTO patent term adjustment record | May 11, 2028 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,273,355) | capped to Mar 25, 2028 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 25, 2028 | High confidence |
This family
| US 8,372,584 | In force no later than Aug 2027 | no later than Aug 2027 |
| US 8,168,389 | In force no later than Nov 2027 | no later than Nov 2027 |
| Application 13/306,640 | Abandoned not computed | not computed |
| Application 13/306,698 | Abandoned not computed | not computed |
| US 9,273,355 | In force Mar 2028 | Mar 2028 |
| US 9,347,100 | In force Jun 2027 | Jun 2027 |
| US 9,017,942 | In force Jun 2027 | Jun 2027 |
| US 10,155,984 | this patent Mar 2028 | Mar 2028 |
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 28, 2016 Reel 37610, frame 453 | Stoughton, Roland; Davis, Ronald W. | Verinata Health, Inc. | Assignment of Assignor's Interest |
| Jan 28, 2016 Reel 37610, frame 516 | Shoemaker, Daniel; Kapur, Ravi | Verinata Health, Inc. | Assignment of Assignor's Interest |
| Jan 28, 2016 Reel 37629, frame 582 | Toner, Mehmet | The General Hospital Corporation; GPB Scientific, LLC | Assignment of Assignor's Interest |
| Jan 28, 2016 reel/frame not recorded | Toner, Mehmet | The General Hospital Corporation | Assignment of Assignor's Interest |
| Jan 28, 2016 reel/frame not recorded | Toner, Mehmet | GPB Scientific, LLC | Assignment of Assignor's Interest |
| Jun 29, 2016 Reel 39045, frame 222 | Cellective DX Corporation | GPB Scientific, LLC | Assignment of Assignor's Interest |
| Nov 9, 2016 Reel 40581, frame 683 | On-Q-Ity, Inc. | GPB Scientific, LLC | Assignment of Assignor's Interest |
| Sep 28, 2023 Reel 65082, frame 354 | GPB Scientific, Inc. | First-Citizens Bank & Trust Company | Security Interest |
| Jun 14, 2024 Reel 67732, frame 146 | Silicon Valley Bank, a Division of First-Citizens Bank & Trust Company | GPB Scientific, Inc. | Release of Security Interest |
| Jun 14, 2024 Reel 67737, frame 606 | GPB Scientific, LLC | GPB Scientific, Inc. | Certificate of Conversion from a Limited Liability Company to a Corporation |
| Jun 14, 2024 Reel 67737, frame 738 | GPB Scientific, Inc. (D/B/A Curate Biosciences) | Curate (ABC), LLC | Assignment of Assignor's Interest |
| Jun 14, 2024 Reel 67737, frame 769 | Curate (ABC), LLC | Zeon Corporation | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2028
Term ends Mar 25, 2028.
Note
The 332 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 9,273,355.
Citations
28
later US patents cite this one
That is top 10% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.